Parkman Healthcare Partners’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.84M | Buy |
2,107,483
+327,029
| +18% | +$1.53M | 1.13% | 30 |
|
|
2025
Q1 | $9.77M | Buy |
1,780,454
+1,201,943
| +208% | +$6.6M | 1.16% | 31 |
|
|
2024
Q4 | $1.96M | Buy |
578,511
+476,118
| +465% | +$1.61M | 0.26% | 72 |
|
|
2024
Q3 | $292K | Buy |
102,393
+1,563
| +2% | +$4.46K | 0.04% | 92 |
|
|
2024
Q2 | $227K | Buy |
100,830
+154
| +0.2% | +$347 | 0.03% | 89 |
|
|
2024
Q1 | $222K | Buy |
+100,676
| New | +$222K | 0.03% | 99 |
|